COVID-19: Vaccines and Therapeutics
At a Glance
House and Senate leaders late yesterday announced an agreement on a roughly $900 billion COVID-19 relief package that includes a number of provisions beneficial to hospitals and health systems. They also agreed on a roughly $1.4 trillion spending package that would fund the federal…
Centers for Medicare & Medicaid Services released updated guidance for states and territories on Medicaid, Children’s Health Insurance Program and Basic Health Program coverage and reimbursement for COVID-19 vaccinations.
The American Medical Association announced Current Procedural Terminology immunization and administration codes for reporting on medical claims the COVID-19 vaccine under development by AstraZeneca and University of Oxford.
The National Institutes of Health announced enrollment in phase 3 of the clinical trial of two disparate therapies. This trial is specifically looking at the safety and effectiveness of the therapeutics in people hospitalized with moderate COVID-19 symptoms.
The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee Dec. 17 recommended the approval of Moderna’s mRNA-1273 COVID-19 vaccine candidate.
To help advance the public’s confidence and trust in the safety of COVID-19 vaccines and their distribution, the AHA has launched a COVID-19 vaccine webpage for individuals.
As the nation grapples with the complicated logistics of fair and efficient vaccine distribution, this conversation with two senior officials from the National Urban League explores best practices and strategies hospitals and health systems can use to reach Black, Latinx and underserved communities…
AHA launched #MyWhy, a social media campaign that amplifies health care workers’ voices on the importance of getting vaccinated against COVID-19.
The Food and Drug Administration Center for Biologics Evaluation and Research Prevention has addressed new information that shipped vials of Pfizer’s BND162b2 mRNA COVID-19 vaccine contain extra doses, indicating that it is acceptable to use every full dose obtainable from each product vial.
Please join AHA Board Chair Melinda Estes, M.D., for the eleventh in a series of Leadership Rounds — short conversations on a range of key issues Dr. Estes will have with hospital and health system leaders from across the country. Dr. Estes was joined by Rodney F. Hochman, M.D., President and CEO,…
- Novel Coronavirus (SARS-CoV-2/COVID-19)
- COVID-19: Organizational Preparedness and Capacity Planning
- COVID-19: Protecting Health Care Workers
- Workforce
- Workforce Shortages
- Well-Being & Resilience
- COVID-19: Caring for Patients and Communities
- COVID-19: Supplies and Personal Protective Equipment (PPE)
- COVID-19: Vaccines and Therapeutics
- Leadership Dialogue